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IN THE FIRST CLINICAL TRIALS of pancreatic trans-
plantation (1, 2), the graft consisted of the whole 
pancreas, duodenum and a short segment of 
jejunum. The duodenal component of the trans-
plant apparently was responsible for a high 
incidence of infection and other lethal 
complications, probably because intestinal rejec-
tion was difficult to control with the immuno-
suppressive therapy then available. In one study 
(3), it was documented how total pancreatic 
transplantation with the duodenal segment was 
abandoned in favor of transplantation of the 
pancreatic body and tail. With these "segmental" 
transplants, the transfer of suboptimal amounts 
of pancreatic tissue, imperfect techniques for 
management of the graft exocrine secretions, vas-
cular thromboses, other technical complications 
and difficulties with the control of rejection have 
contributed to the unsatisfactory results 
throughout the world (4). 
During the last year, four patients with diabe-
tes have been given composite splanchnic organ 
grafts which included the entire pancreas, spleen 
and variable amounts of dUf)denum. For two of 
the recipients, enough jejunum was included to 
allow its anastomosis as a graft Roux-en-Y to the 
gastrointestin.al tract of the recipient. Observa-
tions of the four patients have defined both the 
causes and management of complication specific 
to the intestinal and splenic components of the 
graft. They also have convinced us that our final 
version of a composite organ graft or variations of 
its principle, will come to be the preferred me-
thods of pancreatic transplantation in human 
beings. 
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METHODS 
The donor operation. Except for avoidance of 
blood type ABO incompatibilities and positive 
cytotoxic antibody cross matches, tissue typing 
was done at random (Table I). The D r 3 and 4 
antigens which are strongly associated with 
juvenile-onset diabetes (5) were identified in 
three of the four recipients but none of the donors 
(Table I). The donor age and sex patterns were 
variable (Table I). The grafts were taken from 
multiple organ donors, using the same approach 
as for combined donor hepatectomy and neph-
rectomy (6). The proximal portion of the celiac 
axis was dissected free. The left gastric branch of 
the celiac axis was ligated at its origin. The he-
patic artery was dissected free and ligated beyond 
the gastroduodenal arterial branch (Fig. 1). 
When the superior mesenteric artery was adhe-
rent to the pancreas, it was ligated proximally 
and distally and left with the graft (Fig. 1). 
The spleen and the tail of the pancreas were 
gently mobilized. The first part of the duodenum 
was transected and the distal end was closed in 
two layers (Fig. 1), after stapling or suturing the 
proximal end to prevent contamination. Prepar-
ations were made for in situ perfusion of the kid-
neys and pancreas by placement of cannulas into 
the distal part of the aorta and inferior vena cava 
(6). 
When both the pancreas and nephrectomy 
teams were ready, the aorta was cross clamped 
above the celiac axis and cold lactated Ringer's or 
Collins solution was infused through the aortic 
cannula while vena caval blood was removed and 
while the transected portal vein was bled out. Af-
ter completion of the aortic infusion, an aortic 
patch was removed in continuity with the celiac 
axis and the graft. A variable amount of jejunum 
was kept with the pancreaticoduodenal and 
splenic specimen (Fig. 1). The chilled composite 
graft, was placed in a cold bath of Collins solution 
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FIG. 1. Composite graft removed from donors in preparation for pancreatico-
duodenal transplantation. The long jejunal segment was kept in Patients 1 and 2 
but removed at the backtable along with the distal part of the duodenum in Patients 
3 and 4. The spleen was retained in all except Patient 3. 
until it could be revascularized in the recipient. 
The cold ischemia times before revascularization 
in the recipients ranged from 45 to 140 minutes. 
Recipient selection. Three men and one 
woman, between 30 and 42 years of age (Table I) 
who had been insulin dependent (Type I) 
diabetics for 23 to 29 years, were selected. End-
stage diabetic nephropathy necessitating dialysis 
or transplantation was an obligatory condition of 
candidacy imposed by the Institutional Review 
Board of the Univeristy of Pittsburgh. 
Consequently, the four recipients had undergone 
dialysis for long periods followed by a successful 
cadaveric renal transplantation from three weeks 
TABLE I.-DONOR/RECIPIENT COMPARISON IN IN-
STANCES OF PANCREATIC TRANSPLANTATION 
PatIent No., 
Age, yrs., Antigens of possible 
Sex ABO type DR type -1 matched at A. B loci 
1 
35 
M 0-> A 2,4--> 3 
2 
33 
F 0-> 0 2-> 3,4 0 
3 
30 
M 0-> 0 5,7-> 3,4 0 
4 
42 
M A->A 5-> 3,4 0 
to seven months before pancreatic grafting (Table 
II). Insulin requirements before pancreatic graf-
ting are noted in Table III). 
Patients 1, 2 and 4 had severe sensory and mo-
tor neuropathy of the legs as well as autonomic 
neuropathy characterized by poor motility of the 
gastrointestinal tract and by a fixed heart rate 
that was nonresponsive to exercise (7,8). All four 
patients had undergone multiple ophthalmologic 
procedures, including laser treatments for 
retinopathy. Patient 1 was completely blind in 
one eye and Patient 2 was legally blind. 
The recipient operation. The organs trans-
planted in addition to the entire pancreas are 
summarized in Table II for each patient. The 
spleen was excluded only in Patient 3. In Patients 
1 and 2, the entire duodenum and about 2 feet of 
jejunum were retained initially (Fig. 2), but later, 
it was necessary to remove most of the intestinal 
graft (Fig. 3). In Patients 3 and 4, only the seg-
ment of duodenum into which the ampulla of 
Vater emptied was kept (Fig. 4). 
It was simplest to place the composite organ 
grafts on the left side of the recipient through an 
extraperitoneal lower abdominal incision, keep-
ing the transplanted viscera in the same spatial 
orientation as in the donor. This was possible in 
two patients. The celiac axis and portal vein were 
anastomosed end-to-side to the external or com-
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FIG. 2. Technique of implantation into the left side used in 
Patient 1. The graft jejunum which provided an exit for the 
pancreatic exocrine secretions became a major source of 
morbidity, and eventually, it was removed (Fig. 3.). 
mon iliac vessels (Fig. 2). The pancreas and the 
spleen were placed in the extraperitoneal space. 
A window was made in the peritoneum through 
which an intestinal anastomsis could be 
performed. Identification of the site of the anas-
tomosis to the recipient jejunum was facilitated by 
a short middle midline incision. Details of the in-
testinal connections and their revisions are de-
scribed under the heading Results. 
In two patients, the grafts were placed on the 
right side because a renal graft already occupied 
the lower left part of the extra peritoneal space 
(Fig. 4). With this variation, the specimen was 
rotated 180 degrees so that the spleen was at the 
right (Fig. 4) and the portal vein was inferior. 
The vascular anastomoses were to the iliac vessels 
a b 
c d 
FIG. 3. Operative reVISIOns in Patient 1. a, The entire 
specimen shown in Figure 1 was transplanted. b, Splenec-
tomy was performed after six and one-half days. c, The graft 
jejunum was detached from its anastomosis to recipient je-
junum and brought to the skin of the left lower quadrant. d, 
The graft jejunum and distal part of the duodenum were re-
sected and a "bubble" of duodenum retained for anastomosis 
to the recipient jejunum. (See text for details). 
of the recipient. Provision for an intestinal anas-
tomosis through a peritoneal window was the 
same as on the left side. 
Postoperative immunosuppression. When the 
four patients were given cadaveric kidneys three 
weeks to seven months previously (Table II), they 
were treated with cyclosporine and steroids as 
previously described (9). At the time of the pan-
creatic transplantation, the cyclosporine doses 
were approximately 10 milligrams per kilogram 
per day and the prednisone doses were 20 milli-
TABLE n.-FEATURES OF PANCREATIC TRANSPLANTATION 
PrevIOUS Date Spleen Spleen 
PatIent cadaver pancreas Included later Intestine 
.vo. kzdney TX TX In grajl removed In orgmal graft 
3 mos. 3/06/83 Yes 6\12 Days Duodenum. jejunum 
2 3 wks. 4/09/83 Yes Never Duodenum. jejunum 
3 5 mos. 10/24/83 No Bubble of duodenum 
4 5\12 mos. 12/23/83 Yes 18 Days Bubble of duodenum 
TX. Transplantation. 
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FIG. 4. Pancreaticoduodenal and splenic transplantation 
to the right side of the pelvis in Patient 4. Note that all of the 
jejunum and most of the duodenum were removed, leaving a 
short segment of duodenum closed at both ends which was 
anastomosed side-to-side to the recipient jejunum. 
grams per day. After pancreatic transplantations, 
a five day burst of steroid therapy was given, 
beginning at 200 milligrams per day with de-
crements of 40 milligrams per day until the base 
line dose of 20 milligrams per day had been 
reached. For patients who could not eat during 
the one or two days postoperatively, 6 milligrams 
per kilogram per day of cyclosporine given intra-
venously were substituted for the oral dosage, and 
the intravenous route was overlapped with re-
sumption of the oral dosage for another day or 
two. Subsequently, the cyclosporine and steroid 
dosages were reduced further. Cyclosporine ther-
apy was monitored by frequently measuring the 
venous blood concentration of the drug. 
RESULTS 
All of the four patients are alive with observa-
tion periods of two and a half months to one year. 
The renal function from the previously trans-
planted cadaver kidneys has remained good in all 
four. 
Pancreatic graft function. The graft in Patient 
3 underwent vendus infarction a few hours post-
operatively due to thrombosis of the splenic and 
portal veins. It was removed one day after its 
insertion, and insulin therapy was resumed. The 
other three patients have not required insulin in 
the two and a half, 11 and 12 months since 
operation. After revascularization of the pan-
creatic grafts, the plasma glucose concentrations 
fell at the rate of about 50 milligrams per cent 
everyone-half hour until a euglycemic level was 
reached. Fasting plasma glucose levels have been 
in the normal range, and the results of glucose 
tolerance tests consistently have been normal 
(Fig. 5). A detailed account of the metabolic and 
endocrine changes in these patients will be pub-
lished separately. 
The peripheral neuropathy in the three pa-
tients with functioning grafts has reversed or is 
reversing (Table III). Reversal of autonomic 
neuropathy was also noted and was particularly 
striking in Patient 1 who resumed sexual func-
tion within six months after five years of impo-
tence and who took up jogging and hand ball as 
cardiovascular responsiveness improved. These 
three patients have had stabilization of visual 
complications (Table III). 
Splenic complications. In Patient 3, the spleen 
was removed before transplantation because of 
space limitations. Thrombosis of the venous out-
flow necessitated graft removal one day later. 
Patient 1 who was of A blood type was given a 
composite graft from an 0 donor. The estimated 
blood loss at operation was 100 milliliters. Dur-
ing the next six days, the hematocrit level fell 
from 41 to 21 per cent. After five days, the serum 
haptoglobin level was 35 milligrams per cent, the 
reticulocyte count was 5.5 per cent, the direct and 
indirect bilirubin value had increased to 1.0 and 
2.9 milligrams per cent, respectively, and the 
urine was positive for urobilinogen. The results 
of the direct Coomb's test was positive. Type A 
blood could not be matched with the patient be-
cause of anti-A isoagglutinins which had ap-
peared in the serum. Anti-A isoagglutinins also 
were eluted from the circulating red blood cells. 
Six transfusions of washed group 0 red blood 
cells were given over the next three days to 
stabilize the hematocrit level of the patient. 
After six and a half days, the transplanted 
spleen was removed. It weighed 190 grams. 
Histopathologically, there was red pulp 
congestion, immunoblast proliferation and inti-
mal swelling. Although karyotyping studies were 
not done, the fact that lymphoid expansion oc-
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FIG. 5. The most recent glucose tolerance tests of the three patients with func-
tioning grafts, performed after an overnight fast as recommended by the Diabetes 
Data Group (28), using an glucose challenge of 75 grams taken orally. Impaired 
glucose tolerance is defined as two-hour plasma glucose values between 140 and 
200 milligrams per cent with an intervening value above 200 milligrams per cent. 
Fasting plasma glucose values exceeding 140 milligrams per cent or two-hour plas-
ma glucose values above 200 milligrams per cent accompanied by an intervening 
value above 200 milligrams per cent are diagnostic of diabetes mellitus. All tests are 
within normal limits by these definitions. 
curred predominantly in the marginal zones 
suggested that the proliferating cells were of do-
nor origin. Cells populating the marginal zones 
do not recirculate (10), and in addition, this site is 
directly bathed in host blood and is thought to be 
the major site at which antigen presents to this 
organ (10, 11). Of note, germinal centers were 
absent and no changes were seen in the periarte-
riolar lymphoid sheath. 
Postoperativel y, the hematocrit level stabilized. 
The anti-A isoagglutinins disappeared from the 
serum over the next nine weeks. 
Patient 1 also had a reduction in platelet count 
from 230,000 per cubic millimeter preoperatively 
to 140,000 before graft splenectomy. The change 
did not cause concern, but in Patient 4, who 
received a graft from a donor with the same ABO 
blood type, the decline was from 200,000 to 
22,000 during an 18 day period. After graft 
splenectomy in both Patients 1 and 4, the throm-
bocyte counts were restored to the pre-existing 
level within a few days. In contrast with the his-
topathologic findings in Patient 1, the grafted 
spleen removed from Patient 4 did not show 
marginal zone expansion. 
After 11 months, Patient 2 still has a splenic 
homograft which has been visualized with ra-
dionuclide scans. She has not had hematologic 
complications. 
Intestinal complications. In Patient 1, a 2 foot 
length of graft jejunum was anastomosed to the 
recipient jejunum (Fig. 3 a and b). After a few 
weeks, the patient had cramps, watery diarrhea 
and hypoalbuminemia in the 2 gram per cent 
range. By gastrointestinal tract series and com-
puterized axial tomography, the luminal aspect of 
the graft jejunum was irregular and thickened. At 
reoperation, three months after the original 
procedure, the graft jejunum was detached from 
the recipient intestine and anastomosed to the 
skin of the abdominal wall (Fig. 3c). Although 
the intestine looked almost normal from the 
TABLE IlL-ENDOCRINE GRAFT FUNCTION 
Patient Preop. daily Pastap. daily 
No. insulin unzts insulin unzts Neuropathy Eyesight 
80 NPH, 10 Reg. 0 Reversed Stabilized (one 
eye blind) 
2 100 Lente 0 Reversed Stabilized (legally 
blind) 
3 70 Reg. 70 Reg. Unchanged Unchanged 
4 20NPH.10Reg. 0 Reversing Stabilized 
Reg., Regular. 
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TABLE IV.-PROTEIN CONCENTRATION OF FLUID 
EXCRETED BY PANCREATICODUODENOJEJUNAL 
GRAFT" 
Basal, (mgm. per cent) 
Complement 3 22 
Complement 4 3 
IgG .... .... 50 
IgA ........ 26 
Albumin .... 1,790 
'" antitrypsin. 97 
• Patient I. see Figure 3c. 
Postsecretin (mgm. per cent)t 
22 
3 
56 
27 
1,280 
94 
tSamples were obtained at 15 minutes after an intravenous dose of I clin-
ical unit per kilogram of secretin. 
IgG. Immunoglobulin G; IgA, immunoglobulin A. 
outside, extensive mucosal damage was evident 
both grossly and microscopically. Epithelial de-
struction was accompanied by prominent acute 
and chronic inflammation, the latter composed 
chiefly of T -lymphocytes. The muscularis muco-
sae and deeper layers of intestine were unaffected 
despite the severity of the mucosal granulation. 
Damage was confined to the donor intestine and 
the results of biopsies of adjacent host intestine 
showed intact epithelium. After a week, the jeju-
num and duodenum were examined and biopsies 
taken by insertion of an endoscope through the 
skin stoma. Continued granulation of the mucosa 
was observed. Patchy areas of epithelium over-
lying this process suggested some degree of 
regeneration. Both processes were seen in second 
biopsies taken 15 days later. 
During the 42 days when the skin jejunostomy 
was in place, its daily output ranged between 2 to 
3 liters, a volume greater than expected from an 
otherwise normal pancreas. The protein concen-
tration of the collected luminal content was al-
most 2 grams per cent, a figure that did not 
change greatly with secretin stimulation (Table 
IV). It was concluded that a protein losing enter-
opathy of the 2 or 3 foot duodenojejunal homo-
graft segment was responsible for the loss of 40 to 
60 grams of endogenous protein per day and ac-
counted for the hypoalbuminemia that had 
occurred. At a third operation, the jejunum and 
distal part of the duodenum were removed, leav-
ing a bubble of duodenum which was anastomos-
ed side-to-side with the jejunum of the recipient 
(Fig. 3d). Histologically, continued inflammation 
and granulation tissue were seen in the mucosal 
layer. Epithelial regeneration was patchy and 
was present in a minority of sections. Vascular 
ectasia was now prominent in the submucosa. 
Within a few days, the serum albumin concen-
tration of the recipient rose to normal, and all of 
the intestinal symptoms were relieved. Further 
hospitalization has not been necessary. 
Patient 2, with an original graft that included 
the duodenojejunal segment, also had abdominal 
cramps, diarrhea and hypoalbuminemia. At a 
second operation six months post-trans-
plantation, the jejunum and distal part of the 
duodenum were removed, leaving a proximal 
duodenal bubble that was anastomosed to the 
jejunum of the recipient. The resected portion of 
intestine bore a striking histologic resemblance to 
that from Patient 1. Within a week, the 
symptoms were relieved and the serum albumin 
level rose from 2.0 to 3.5 grams per cent. The fi-
nal enteric reconstruction reached by stages in 
Patients 1 and 2 (Fig. 3d) was used at the time of 
transplantation for Patients 3 and 4 (Fig. 4). 
DISCUSSION 
The slowly evolving but cumulatively dramatic 
benefits of successful pancreatic transplantation 
were epitomized by the patients we studied. The 
three who retained the grafts have never required 
insulin after operation. They have had multiple 
normal glucose tolerance tests and fasting blood 
glucose concentrations during the subsequent two 
and one-half, 11 and 12 months. The reversal of 
neuropathy and the stabilization of small vessel 
disease and eye complaints have been striking. 
Although other workers have noted the same 
things in isolated instances, attempts at pan-
creatic transplantation usually have failed (1-4). 
The poor results can be explained partly by con-
ceptual flaws, including the use of too little pan-
creas or ineffective strategies for dealing with 
exocrine secretions in many of the transplant 
procedures used until now. 
The logic of transplanting the entire pancreas 
as part of a composite organ graft is evident from 
the most casual inspection of the upper abdomi-
nal viscera in both human beings and animals. 
The duodenum and spleen share the blood supply 
of the pancreas to which they are intimately 
adherent, and in addition, the duodenum receives 
the exocrine pancreatic secretions. 
Thus, it was not surprising that pancreatico-
duodenal grafts were used in the acute experi-
ments performed upon animals reported long ago 
(12) and many years later (13). The pancreas, 
duodenum, jejunum and spleen were part of the 
complex visceral grafts studied by us more than 
20 years ago from which pancreatic function was 
demonstrated during the five and a half to nine 
day postoperative lives of five dogs (14). Although 
immunosuppression was not used, these were the 
first examples of sustained pancreatic homograft 
function. 
Most of the grafts transplanted under immu-
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nosuppression in the pioneering work done by 
Lillehei and co-workers in dogs (2, 15) and even-
tually in humans (1, 2, 16) consisted of all of the 
pancreas, the duodenum and a short section of 
jejunum. Poor results both in animals and hu-
mans after such procedures caused their aban-
donment in favor of the suboptimal partial pan-
creatic grafts from which the exocrine secretions 
have posed special technical problems (3, 4). 
Eventually, the issue of pancreaticoduodenal 
transplantation was reopened by the results of the 
canine studies of Diliz-Perez and associates using 
cyclosporine and steroid therapy (17). 
Aside from providing a complete pancreas, the 
advantages of the composite splanchnic organ 
grafts are principally technical. A large volume of 
blood flow through the graft is assured, particu-
larly if the spleen is included. Large caliber vas-
cular anastomoses can be directed into the intes-
tinal tract through conventional and generally 
low-risk enteric anastomoses. 
In addition, there may be a subtle immunologic 
advantage for the pancreas of having the addi-
tional antigen mass provided by extra pancreatic 
tissues. Mitigation or delay of the rejection of in-
dividual organs has been described when they 
were transplanted as part of a multiple organ 
complex (14, 18) and the spleen has been men-
tioned frequently as a beneficial companion or-
gan for the kidney (19-21), skin (21, 22) and 
pancreas (23) in such diverse species as the dog, 
rat and guinea pig. 
Nevertheless, the inclusion of the extrapan-
creatic organs has been responsible for morbidity, 
and in this study, the liabilities specific to both the 
spleen and intestine have been defined. The 
spleen was responsible for examples of hemolytic 
anemia and thrombocytopenia, complications of 
splenic transplantation that were recognized two 
decades ago in dogs (20, 24) and in humans (20, 
25). 
The hematologic disorders in the two patients 
in our study may have been related in part to an-
tibody production by the splenic grafts. Small 
amounts of lymphoid tissue carried with ortho-
topic liver grafts have been shown to produce new 
immunoglobulin phenotypes in hepatic recipients 
(26). Theoretically, the vastly greater B-
lymphoid mass in a splenic graft could jeopardize 
the recipient by producing large quantities of 
graft versus host antibodies that could react 
against formed blood elements and tissues. There 
was no direct evidence for this in the patient with 
severe acquired thrombocytopenia, although the 
complication was promptly relieved by graft 
splenectomy. However, the hypothesis was par-
ticularly tempting in Patient 1, an A blood type 
recipient who was given a spleen from an 0 
donor. Anti-A isoagglutinins produced by the 
grafted 0 type spleen apparently were responsi-
ble for a positive Coomb's test result, hemolytic 
anemia and jaundice. All were relieved by 
splenectomy. 
Notwithstanding these complications, we plan 
to include the spleen in future total pancreatic 
grafts providing there is donor-recipient ABO 
identity. Delayed splenectomy in the two patients 
with hematologic complications was extraordi-
narily easy, being accomplished in a few minutes 
after opening the lateral end of the extraperito-
neal wound. By the end of six and a half to 18 
days, the rest of the graft had mature 
revascularization. The only technical accident in 
the four recipients in our study was venous 
thrombosis of a graft from which the spleen had 
been removed prior to implantation. 
In contrast, we intend to eliminate as much in-
testine as possible from future pancreatic grafts, 
as was done from the outset in Patients 3 and 4, 
leaving only enough duodenum at the level of the 
ampulla of Vater for a side-to-side anastomosis to 
recipient jejunum (Fig. 4). In the first two 
patients, the duodenum and jejunum in excess of 
this minumum amount became denuded of 
epithelium. A major protein losing enteropathy 
resulted. Whether the intestinal injury was 
caused by rejection, ischemia or other factors 
could not be determined, but the disabling con-
sequences have dampened the enthusiasm for a 
clinical trial of intestinal transplantation under 
cyclosporine and steroid therapy that had been 
justified by the results of research done on dogs 
(27). 
SUMMARY 
Whole cadaveric pancreata were transplanted 
to the pelvic extraperitoneal location in four pa-
tients with diabetes who previously had under-
gone successful cadaveric renal transplantation. 
One graft was lost within a few hours from ve-
nous thrombosis but with patient survival. The 
other three are providing normal endocrine func-
tion after two and a half, 11 and 12 months. The 
exocrine pancreatic secretions were drained into 
the recipient jejunum through enteric 
anastomoses. Because mucosal slough of the graft 
duodenum and jejunum in two patients caused a 
protein losing enteropathy and necessitated 
reoperations, we now do the pancreatic trans-
plantation with only a blister of graft duodenum 
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large enough for side-to-side enteroenterostomy. 
The spleen has been transplanted with the pan-
creas mainly for technical reasons, and this tech-
nique should have further trials in spite of the fact 
that delayed graft splenectomy became necessary 
in two recipients to treat graft induced hemato-
logic complications. 
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